UMBRALISIB DISCONTINUED | UMBRALISIB | ATC L01EX25
ANTINEOPLASTIC TREATMENT OF LYMPHOMA KINASE INHIBITOR (PI3K-DELTA, CASEIN KINASE CK1-EPSILON) | ORAL | Cmax 12.8 MICROMOLAR Tmax 4 HOUR VD 312 LITER PPB 99.7 PERCENT Cl 15.5 LITER / HOUR HT 91 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER (PKA=2.71) | PI3K-DELTA CASEIN KINASE CK1-EPSILON | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |